Drug and Alcohol Dependence
Volume 108, Issue 1 , Pages 49-55 , 1 April 2010

Mechanisms underlying the lifetime co-occurrence of tobacco and cannabis use in adolescent and young adult twins

  • Arpana Agrawal

      Affiliations

    • Washington University School of Medicine, Department of Psychiatry, 660 S. Euclid CB 8134, St. Louis, MO 63110, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 314 286 1778; fax: +1 314 286 2213.
  • ,
  • Judy L. Silberg

      Affiliations

    • Virginia Institute for Psychiatric and Behavioral Genetics, Department of Human Genetics, Richmond, VA 23220, United States
  • ,
  • Michael T. Lynskey

      Affiliations

    • Washington University School of Medicine, Department of Psychiatry, 660 S. Euclid CB 8134, St. Louis, MO 63110, United States
  • ,
  • Hermine H. Maes

      Affiliations

    • Virginia Institute for Psychiatric and Behavioral Genetics, Department of Human Genetics, Richmond, VA 23220, United States
  • ,
  • Lindon J. Eaves

      Affiliations

    • Virginia Institute for Psychiatric and Behavioral Genetics, Department of Human Genetics, Richmond, VA 23220, United States

Received 2 July 2009 ,Revised 12 November 2009 ,Accepted 14 November 2009.

References 

  1. Adler I, Kandel DB. Cross-cultural perspectives on developmental stages in adolescent drug use. J. Stud. Alcohol. 1981;42:701–715
  2. Agrawal A, Lynskey M. The genetic epidemiology of cannabis use, abuse and dependence: a review. Addiction. 2006;101:801–812
  3. Agrawal A, Lynskey MT. Tobacco and cannabis co-occurrence: does route of administration matter?. Drug Alcohol Depend. 2009;99:240–247
  4. Agrawal A, Madden P, Bucholz K, Heath A, Lynskey M. Transitions to regular smoking and to nicotine dependence in women using cannabis. Drug Alcohol Depend. 2008;95:107–114
  5. Agrawal A, Lynskey MT, Bucholz KK, Martin NG, Madden PA, Heath AC. Contrasting models of genetic co-morbidity for cannabis and other illicit drugs in adult Australian twins. Psychol. Med. 2007;37:49–60
  6. Agrawal A, Wetherill L, Dick DM, Xuei X, Hinrichs A, Hesselbrock V, et al. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008;
  7. Akaike H. Factor analysis and AIC. Psychometrika. 1987;52:317–332
  8. Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M. The child and adolescent psychiatric assessment (CAPA). Psychol. Med. 1995;25:739–753
  9. Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am. J. Public Health. 1995;85:41–47
  10. Chen X, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC, et al. Cannabinoid receptor 1 gene association with nicotine dependence. Arch. Gen. Psychiatry. 2008;65:816–824
  11. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys 1. PLoS Med. 2008;5:e141
  12. Degenhardt L, Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction. 2001;96:1603–1614
  13. Eaves LJ, Silberg JL, Meyer JM, Maes HH, Simonoff E, Pickles A, et al. Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the Virginia Twin Study of Adolescent Behavioral Development. J. Child Psychol. Psychiatry. 1997;38:965–980
  14. Fowler T, Lifford K, Shelton K, Rice F, Thapar A, Neale MC, et al. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction. 2007;102:413–422
  15. Golub A, Johnson BD, Dunlap E. The growth in marijuana use among American youths during the 1990s and the extent of blunt smoking 2. J. Ethn. Subst Abuse. 2005;4:1–21
  16. Han C, McGue MK, Iacono WG. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction. 1999;94:981–993
  17. Hawkins JD, Hill KG, Guo J, Battin-Pearson SR. Substance use norms and transitions in substance use: implications for the gateway hypothesis. In:  Kandel D editors. Stages and Pathways of Drug Involvement. New York, NY: Cambridge University Press; 2002;p. 42–64
  18. Heath AC, Cates R, Martin NG, Meyer J, Hewitt JK, Neale MC, et al. Genetic contribution to risk of smoking initiation: comparisons across birth cohorts and across cultures. J. Subst Abuse. 1993;5:221–246
  19. Hewitt JK, Silberg JL, Rutter M, Simonoff E, Meyer JM, Maes H, et al. Genetics and developmental psychopathology: 1. Phenotypic assessment in the Virginia Twin Study of Adolescent Behavioral Development. J. Child Psychol. Psychiatry. 1997;38:943–963
  20. Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, et al. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006;141:895–901
  21. Kandel D. Stages in adolescent involvement in drug use. Science. 1975;190:912–914
  22. Kandel D. Stages and Pathways of Drug Involvement. New York, NY: Cambridge University Press; 2002;
  23. Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Arch. Gen. Psychiatry. 1975;32:923–932
  24. Kandel D, Yamaguchi K. From beer to crack: developmental patterns of drug involvement. Am. J. Public Health. 1993;83:851–855
  25. Kandel DB. Does marijuana use cause the use of other drugs?. JAMA. 2003;289:482–483
  26. Kandel DB, Yamaguchi K. Developmental patterns of the use of legal, illegal, and medically prescribed psychotropic drugs from adolescence to young adulthood. NIDA Res. Monogr. 1985;56:193–235
  27. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J. Stud. Alcohol. 1992;53:447–457
  28. Kelly BC. Bongs and blunts: notes from a suburban marijuana subculture 1. J. Ethn. Subst Abuse. 2005;4:81–97
  29. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry. 2003;160:687–695
  30. Kendler KS, Myers J, Prescott CA. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence 1. Arch Gen Psychiatry. 2007;64:1313–1320
  31. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol. Med. 1999;29:299–308
  32. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry. 2003;60:929–937
  33. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch. Gen. Psychiatry. 2008;65:674–682
  34. Klein DN, Riso LP. Psychiatric disorders: problems of boundaries and comorbidity. In:  Costello CG editors. Basic Issues in Psychopathology. New York: Guilford; 1994;p. 19–66
  35. Korhonen T, Huizink AC, Dick DM, Pulkkinen L, Rose RJ, Kaprio J. Role of individual, peer and family factors in the use of cannabis and other illicit drugs: a longitudinal analysis among Finnish adolescent twins. Drug Alcohol Depend. 2008;97:33–43
  36. Lynskey MT, Fergusson DM, Horwood LJ. The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. J. Child Psychol. Psychiatry. 1998;39:995–1005
  37. Lynskey MT, Heath AC, Nelson EC, Bucholz KK, Madden PA, Slutske WS, et al. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol. Med. 2002;32:195–207
  38. Mackay J, Eriksen M, Shafey O. The Tobacco Atlas. Nyraid Editions, Limited edn.. The American Cancer Society; 2006;
  39. Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ, et al. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol. Med. 2004;34:1251–1261
  40. Maes HH, Woodard CE, Murrelle L, Meyer JM, Silberg JL, Hewitt JK, et al. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. J. Stud. Alcohol. 1999;60:293–305
  41. Mathers M, Toumbourou JW, Catalano RF, Williams J, Patton GC. Consequences of youth tobacco use: a review of prospective behavioural studies. Addiction. 2006;101:948–958
  42. McGue M, Elkins I, Iacono WG. Genetic and environmental influences on adolescent substance use and abuse. Am. J. Med. Genet. 2000;96:671–677
  43. McGue M, Iacono WG. The adolescent origins of substance use disorders. Int. J. Methods Psychiatry Res. 2008;17:S30–S38
  44. Neale, M.C., 2004. Statistical Modeling with Mx. Dept. of Psychiatry, Box # 980710, Richmond, VA 23298.
  45. Neale MC, Harvey E, Maes HH, Sullivan PF, Kendler KS. Extensions to the modeling of initiation and progression: applications to substance use and abuse. Behav. Genet. 2006;36:507–524
  46. Neale MC, Kendler KS. Models of comorbidity for multifactorial disorders. Am. J. Hum. Genet. 1995;57:935–953
  47. Oetting ER, Beauvais F. Peer cluster theory: drugs and the adolescent. J. Counseling Development. 1986;65:17–22
  48. Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction. 2005;100:1518–1525
  49. Patton GC, Coffey C, Carlin JB, Sawyer SM, Wakefield M. Teen smokers reach their mid twenties. J. Adolesc. Health. 2006;39:214–220
  50. Rhee SH, Hewitt JK, Lessem JM, Stallings MC, Corley RP, Neale MC. The validity of the Neale and Kendler model-fitting approach in examining the etiology of comorbidity. Behav. Genet. 2004;34:251–265
  51. Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Neale MC, et al. Comorbidity between alcohol dependence and illicit drug dependence in adolescents with antisocial behavior and matched controls. Drug Alcohol Depend. 2006;
  52. Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Stallings MC. Genetic and environmental influences on substance initiation, use, and problem use in adolescents. Arch. Gen. Psychiatry. 2003;60:1256–1264
  53. Rhee SH, Neale MC, Corley RC, Hewitt JK. The inclusion of measured covariates in the Neale and Kendler model fitting approach 1. Behav. Genet. 2007;37:423–432
  54. Rose RJ. A developmental behavior-genetic perspective on alcoholism risk. Alcohol Health Res. World. 1998;22:131–143
  55. Rose RJ, Broms U, Korhonen T, Dick D, Kaprio J. Genetics of smoking behavior. In:  Kim Y-K editors. Handbook of Behavior Genetics. New York: Springer Science+Business Media; 2009;p. 411–433
  56. Scarr S. Developmental theories for the 1990s: development and individual differences. Child Dev. 1992;63:1–19
  57. Silberg J, Meyer J, Pickles A, Simonoff E, Eaves L, Hewitt J, et al. Heterogeneity among juvenile antisocial behaviours: findings from the Virginia Twin Study of Adolescent Behavioural Development. Ciba Found. Symp. 1996;194:76–86
  58. Silberg JL, Rutter M, Tracy K, Maes HH, Eaves L. Etiological heterogeneity in the development of antisocial behavior: the Virginia Twin Study of Adolescent Behavioral Development and the Young Adult Follow-Up 1. Psychol. Med. 2007;37:1193–1202
  59. Simonoff E, Pickles A, Meyer JM, Silberg JL, Maes HH, Loeber R, et al. The Virginia Twin Study of Adolescent Behavioral Development. Influences of age, sex, and impairment on rates of disorder. Arch. Gen. Psychiatry. 1997;54:801–808
  60. Substance Abuse and Mental Health Services Administration (SAMHSA). 2004 National Survey on Drug Use and Health. 2005. Ref Type: Internet Communication.
  61. Spitzer RL, Williams JB, Gibbon J. Structured Clinical Interview for DSM-III-R: Patient Version (SCID-P). New York: New York State Psychiatric Institute; 1987;
  62. Timberlake DS, Haberstick BC, Hopfer CJ, Bricker J, Sakai JT, Lessem JM, et al. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug Alcohol Depend. 2007;88:272–281
  63. Vihavainen T, Relander TR, Leiviska R, Airavaara M, Tuominen RK, Ahtee L, et al. Chronic nicotine modifies the effects of morphine on extracellular striatal dopamine and ventral tegmental GABA. J. Neurochem. 2008;107:844–854
  64. Williams LJ, Holahan PJ. Parsimony-based fit indices for multiple-indicator models: do they work?. Struct. Equation Modeling. 1994;1:161–189
  65. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood: III. Predictors of progression. Am. J. Public Health. 1984;74:673–681
  66. Young SE, Rhee SH, Stallings MC, Corley RP, Hewitt JK. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific?. Behav. Genet. 2006;36:603–615

PII: S0376-8716(09)00425-6

doi: 10.1016/j.drugalcdep.2009.11.016

Drug and Alcohol Dependence
Volume 108, Issue 1 , Pages 49-55 , 1 April 2010